Compare HURA & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HURA | LEE |
|---|---|---|
| Founded | 2009 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Newspapers/Magazines |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5M | 173.8M |
| IPO Year | 2010 | 2025 |
| Metric | HURA | LEE |
|---|---|---|
| Price | $2.18 | $7.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 162.8K | 26.5K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $543,955,000.00 |
| Revenue This Year | N/A | $5.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.41 | $3.34 |
| 52 Week High | $3.43 | $11.88 |
| Indicator | HURA | LEE |
|---|---|---|
| Relative Strength Index (RSI) | 53.15 | 35.05 |
| Support Level | $2.04 | $7.01 |
| Resistance Level | $2.24 | $8.79 |
| Average True Range (ATR) | 0.09 | 0.37 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 87.50 | 5.14 |
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.